Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2016 | 10-2015 | 07-2015 | 04-2015 | 01-2015 | |
| Sales | 250 | 0 | 0 | 0 | 0 |
| Gross Profit | 250 | N/A | N/A | N/A | N/A |
| Operating Expenses | 20,202 | 0 | 13,629 | 13,840 | 6,776 |
| Operating Income | -19,952 | N/A | -13,629 | -13,840 | -6,776 |
| Other Income | 121 | 0 | 67 | -15 | -258 |
| Pre-tax Income | -19,831 | 0 | -13,562 | -13,855 | -7,034 |
| Income Tax | 14 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -19,845 | N/A | -13,562 | -13,855 | -7,034 |
| Net Income | $-19,845 | $N/A | $-13,562 | $-13,855 | $-7,034 |
| EPS Basic Total Ops | -707.65 | N/A | -527.74 | -623.69 | -395.80 |
| EPS Basic Continuous Ops | -706.61 | N/A | -525.47 | -623.45 | -391.46 |
| EPS Diluted Total Ops | -707.65 | N/A | -527.74 | -623.69 | -395.80 |
| EPS Diluted Continuous Ops | -706.61 | N/A | -525.47 | -623.45 | -391.46 |
| EBITDA(a) | $-19,765 | $N/A | $-13,563 | $-13,782 | $-6,721 |